------------------------------------------------------------
[link removed]


** On this HVAD, Accelerating Vaccine Development for HIV and COVID-19
------------------------------------------------------------
May 18, 2020

Dear Advocate,

This HIV Vaccine Awareness Day ([link removed]) a global audience is fixated on the need for vaccines. The COVID-19 pandemic has people struggling to understand the science, the development process and the necessity of a vaccine. Taking in these lessons is no less vital for HIV. AVAC’s new report, Five “P”s to ([link removed]) Watch ([link removed]) : Platforms, process, partnerships, payers and participatory practices that drive vaccine development ([link removed]) , connects these key issues and lays out how HIV vaccine research is making the search for a COVID-19 vaccine faster, smarter and more inclusive.
The connections between HIV and COVID-19 research offer unprecedented opportunities to tell the story of vaccine research. Read Five “P”s to Watch ([link removed]) to help tell that story: a durable, sustainable end to HIV depends on a vaccine, and investment in HIV has created the know-how leveraged today against COVID-19—on multiple levels.

AVAC has other essential resources for HVAD 2020!

Check out our dedicated page on HVAD 2020 ([link removed]) , featuring a toolkit ([link removed]) and details on related webinars to support advocacy and action, including:
* Key Messages ([link removed]) : Frames priorities and unique opportunities for vaccine advocacy for HIV, COVID-19 and future epidemics.
+ Full ([link removed]) : This complete set of messages provides more detail and background on priority messages.
+ Short ([link removed]) : The short form of key messages distills priorities into a curated set of quick and easy-to-use statements.
* Social Media Package ([link removed]) : Draft messages and images we hope you’ll use to extend the reach of our collective messaging this HVAD.
* HIV Vaccines, An Introductory Factsheet ([link removed]) : Basic information on concepts and trials in vaccine research.
* Webinar with Science Magazine’s Jon Cohen ([link removed]) . Download the recording to hear Jon talk about the fast-growing pipeline of vaccine candidates for COVID-19, how COVID-19 research is evolving and building on HIV vaccine research and more!
* AVAC’s latest podcast episode of Px Pulse ([link removed]) features leading voices from HIV vaccine and prevention research talking about the intersection of HIV and COVID-19.
* Watch for an upcoming June webinar with NIH’s Vaccine Research Center for updates on the COVID-19 vaccine pipeline and more!

Let HVAD 2020 be a day you find inspiration and tools to lend your voice to the story of vaccine research, development and delivery – for HIV, COVID-19 and global health generally.

Best,
AVAC

P.S.

Injectable PrEP Effective in MSM and Transgender Women
Breaking news: bi-monthly injections of long-acting cabotegravir (CAB-LA) appear to be safe and effective in preventing HIV in cisgender men and transgender women who have sex with men. If you are looking for more information, check out this post to AVAC’s Advocates Network ([link removed]) .

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])